期刊文献+

抗癌药Ⅰ期临床试验中的拓展性队列研究解析

The Expansion Cohort Study in Phase Ⅰ Trial for Anti-cancer Drug-the Conception and Analysis of its Application
下载PDF
导出
摘要 通过阐述传统Ⅰ期临床试验在抗癌创新药临床研究中的局限性,归纳并剖析最新的拓展性队列试验的定义、目的和特征,梳理该拓展性队列试验设计的应用范围和注意事项,旨在为我国抗癌创新药临床试验设计方法学提供参考。 This article show the limitations of traditional phase I trial in development of novel anti-cancer drug,analyze and summarize the definition,objective and characteristic of expansion cohort trial,interpret the applications and consideration of expansion cohort trial.We hope it can help to provide methodological insight into the use of expansion cohort for anti-cancer drug development in our country.
作者 黄亚芳 谢文杰 HUANG Ya-fang;XIE Wen-jie(School of General Practice and Continuing Education,Capital Medical University,Beijing 100069,China;Department Clinical Research,Inselspital,University of Berne,Bern 3010,Switzerland)
出处 《中国药物评价》 2018年第6期444-449,共6页 Chinese Journal of Drug Evaluation
基金 北京市优秀人才项目(项目编号:2016000020124G097)
关键词 拓展性队列 临床试验 Ⅰ期试验 抗癌药 Expansion cohort Clinical trial Phase I trial Anti-cancer drug
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部